from Stocks-Markets-Economic Times https://ift.tt/3b8d95E
Home »
Stocks-Markets-Economic Times
» Covid drug: Natco eyes patent waiver
Covid drug: Natco eyes patent waiver
from Stocks-Markets-Economic Times https://ift.tt/3b8d95E
Related Posts:
Marico, Jubilant face a tough ask on moves to expand menuThe decision to launch ‘Saffola Oodles’ seems to be in sync with its overall strategy to be in health and wellness products. The fast-moving consumer goods company is already present in the healthier categories of oats, break… Read More
UPL to refinance Arysta M&A debt with $500 million green loansFirst Indian co to raise sustainability linked loans; to reduce carbon emissions, water usage and waste over 5 years from Stocks-Markets-Economic Times https://ift.tt/3ukeNJh … Read More
14,900-15,100 to decide if Nifty falls or risesOn the weekly chart, the index has formed a bearish candle and has closed below the previous week’s low which remains a bearish sign. from Stocks-Markets-Economic Times https://ift.tt/2NrFD1w … Read More
Nifty could stage a bounce this week: AnalystsHowever, on Friday, when the market closed almost a percent lower to 14,981.75, the difference between marketwide calls to puts sold narrowed slightly to Rs 25,141 crore. from Stocks-Markets-Economic Times https://ift.tt/2Ni… Read More
UTI’s offer better suited for old handsInvestors looking for a relatively low-cost fund based on quantitative strategies could consider the New Fund Offer (NFO) of UTI Nifty 200 Momentum 30 Fund. from Stocks-Markets-Economic Times https://ift.tt/2NQX9Mg … Read More
0 Comments:
Post a Comment